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The heart failure epidemic
Heart failure is a true medical epidemic for 
several reasons. Indeed, as societies age in the 
Western world, with long-standing high blood pres-
sure in many individuals and the high survival rate 
of myocardial infarction thanks to effective inter-
ventional techniques, the prevalence and incidence 
of heart failure has continuously increased. This is 
associated not only with an impaired quality of life 
of the patients, but also with considerable costs for 
the health care systems and the society at large.
The main causes of heart failure are longstand-
ing hypertension, arrythmias, coronary artery 
disease, mutations in genes of the contractile 
apparatus and valvular heart disease (Figure 1).
Figure 1. Most important causes of heart failure including hypertension, arrhythmias, coronary artery disease, genetics 
and valvular heart disease.
Increasing therapeutic options
Although, initially, heart failure was a condition 
with very unfavourable outcomes, recent develop-
ments of the management of such patients has 
markedly increased their longevity and reduced 
hospitalisations. Thanks to this medical progress 
today, cardiologists have many therapeutic options 
at hand, such as life style changes and rehabilita-
tion, drugs, revascularisation with percutaneous 
coronary intervention or bypass surgery and val-
vular interventions, pacemakers and implantable 
cardioverter defibrillators (ICD), as well as cardiac 
resynchronisation therapy, and finally left ventricu-
lar assist devices (Figure 2). For selected patients, 
even heart transplantation may be an option.
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With these options the outcome of heart failure 
patients could be markedly improved both in re-
ducing hospitalisations for heart failure and death.
Thus, heart failure doctors need an excellent 
training in all diagnostic and treatment modalities 
to properly take care of their patients.
The London PCHF
The new London Postgraduate Course in 
Heart Failure (THE LONDON PCHF), organised 
by the Royal Brompton and Harefield Hospitals 
and its Institute for Medicine and Science with 
support from the British Cardiovascular Society 
and the British Society for Heart Failure offers an 
educational programme at the highest academic and 
medical level. The experience and commitment of 
the Zurich Heart House and his educational team 
provides overall professional support for faculty 
and participants. The course directors are respon-
sible for the content of the programme (Figure 3).
Course participants
The participants have been selected from 
close to 200 applicants by the Advisory Board of 
the London PCHF. Eventually, 64 participants from 
32 countries mainly from Europe, but also from the 
far east, South Africa and the Americas have been 
accepted. Of note, half of the participants each are 
of female and male gender. The requirements for 
application included a board certificate in cardiology 
(or shortly before it), interest in heart failure, pub-
Figure 2. Therapeutic options in heart failure.
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Figure 3. Directors of the London PCHF.
Figure 4. Participants from Poland (from left to right): 
Michal Bohdan, Malgorzata Lelonek, Maria Niespialowska- 
-Steuden (Credit J. Lipton)
Figure 5. Opening Session of the London PCHF with Bertram Pitt, Teresa McDonagh, Martin Cowie, John Cleland and 
Christian Mueller.
Figure 6. Paul Kalra discusses clinical cases in a breakout session (Credit J. Lipton).
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lications on the topic and a recommendation letter 
by a supervisor. All 64 cardiologists participated in 
the first module that took place on January 16–19, 
2019 at The Royal Society of Medicine, in Central 
London, as well as practical courses at the Royal 
Brompton and Harefield Hospitals, among them 
also three young cardiologists from Poland who 
were heardly welcomed (Figure 4).
Course structure
The course contains 6 modules of 4 days of 
lectures, interactive sessions, live transmissions 
and case presentations by the participants over 
a 2-year period.
The first module addressed the topic ‘How to 
Approach Heart Failure’ chaired by Bertram Pitt 
from Ann Arbor, Michigan and began with lectures 
from eminent cardiologists such as Martin Cowie 
and Theresa McDonagh from London as well as 
Christian Mueller from Basle, Switzerland (Figure 5). 
The importance and assessment of heart failure was 
reviewed. These topics were further pursued in 
Rapid Fire Sessions (Figure 6) and presentations of 
challenging cases by the participants themselves. An 
important subject was the pathophysiology of heart 
failure reviewed by John Cleland from Glasgow, the 
haemodynamic changes and changes in the cardiac 
marker structure in such patients reviewed by 
Stephan Rosenkranz from Cologne, Germany.
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A highlight was a LIVE demonstration of 
an ergospirometry by both a pulmonologist and 
a cardiologist with an on-line transmission of the 
detailed oxygen metabolism as well as cardio-
haemodynamic parameters (Figure 7). This was 
followed by another LIVE transmission by Roxy 
Senior and his team of a stress echocardiography 
with contrast, which impressively demonstrated 
the potential of this examination, if performed at 
such a professional level.
The first module was further complemented by 
lectures on comorbidities in heart failure by Christian 
Figure 8. Hands-on echocardiography session at the Royal Brompton Hospital.
Figure 7. Live demonstration of an ergospirometry by Luke Howard and Daniel Dumitrescu (Credit J. Lipton).
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Angermann from Würzburg, Germany, diabetes and 
coronary artery disease and heart failure by Martin 
C. Petrie from Glasgow and finally on stunning and 
hibernation by Gerd Heusch from Essen, Germany.
Furthermore, diagnostic procedures such as 
left and right heart catheterisation and coronary 
angiography were demonstrated in impressive 
Live-in-a-box sessions by Stefan Rosenkranz and 
Ronald Binder from Wels, Austria.
For the assessment of patients with heart 
failure imaging technologies play a crucial role, 
as was outlined by highly educational lecture 
by Jeroen J. Bax, the former ESC President, on 
echocardio graphy and by Sanjay Prasad and Dudley 
Pennel from London on cardiac magnetic resonance 
imaging and Ronald Büchel from Zurich, on hybrid 
imaging to guide revascularisation in heart failure.
The Saturday part of the course focused on 
congenital heart disease with eminent lectures by 
Michael Gatzoulis, Andrew Bolger and Sonya Babu-
Narayan followed by hands-on echo sessions, in 
small groups, at the Royal Brompton and Harefield 
Hospitals (Figure 8).
Thus, the London Postgraduate Course on 
Heart Failure started very successfully with happy 
participants and organizers and will continue in 
June with model 2, again at the Royal Society of 
Medicine in London. 
